A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients
ConclusionThe 12-gene prognostic model may serve as a useful complementary clinical risk-stratification tool for stage I and especially stage IA lung squamous cell carcinoma patients to guide clinical decision making.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Genetics | Skin Cancer | Squamous Cell Carcinoma | Training | Universities & Medical Training